Related Articles
Thymidine kinase 1: A proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients
Serum thymidine kinase 1 reflects the progression of pre-malignant and malignant tumors during therapy
Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity